Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

MannKind's Afrezza And The Oramed Threat
Seeking Alpha
Thursday, May 23, 2013 - 10:29am
tags:
MannKind, Afrezza, diabetes, Oramed Pharmaceuticals, ORMD-0801
[video]Merck's Magic Sleeping Pills Wake Up Big Pharma
Bloomberg
Thursday, May 23, 2013 - 10:25am
tags:
insomnia, Merck, suvorexant
Lpath Initiates Dosing in First Proof-of-Concept Trial of Anti-Cancer Drug, ASONEP
Yahoo
Thursday, May 23, 2013 - 10:01am
tags:
Lpath, Asonep, renal cell carcinoma
Merrimack completes enrollement in a Phase 2 study of MM-121 with Sanofi
The Fly on the Wall
Thursday, May 23, 2013 - 9:44am
tags:
Merrimack Pharmaceuticals, MM-121, breast cancer
J&J Sees 10 Products Submitted For Approval by 2017
Bloomberg
Thursday, May 23, 2013 - 9:42am
tags:
JNJ, drug approvals
Pfizer takes its shot at a vaccine for evasive superbug
Yahoo/Reuters
Thursday, May 23, 2013 - 9:39am
tags:
vaccine, Pfizer, MRSA
FDA panel favors Merck sleeping aid despite safety concerns over drowsiness, driving issues
Yahoo/AP
Wednesday, May 22, 2013 - 5:26pm
tags:
FDA, Merck, suvorexant, insomnia, advisory panels
Specialty drugs to rocket upward by 67% by 2015
Fierce Pharma
Wednesday, May 22, 2013 - 4:45pm
tags:
specialty pharma, IMS, prescription data
MannKind shares leap as web site says firm is a ripe takeover target
Marketwatch
Wednesday, May 22, 2013 - 4:44pm
tags:
MannKind, M&A
Ariad's Cancer Drug Iclusig Extends The Gleevec Magic
Seeking Alpha
Wednesday, May 22, 2013 - 4:42pm
tags:
Gleevec, Ariad Pharmaceuticals, Iclusig, CML, Novartis, chronic myeloid leukemia
4 Big Drug Companies With Big Juicy Yields
Motley Fool
Wednesday, May 22, 2013 - 4:41pm
tags:
Merck, Pfizer, Teva, Eli Lilly
Warner Chilcott CEO up for $9.2M handshake after Actavis deal
Fierce Pharma
Wednesday, May 22, 2013 - 11:59am
tags:
Warner Chilcott, M&A, Actavis, Pharma CEOs, executive pay, Roger Boissonneault
These 2 Patents Could Mean Everything Or Nothing
Seeking Alpha
Wednesday, May 22, 2013 - 11:56am
tags:
patents, Amarin, Celsion, Vascepa, ThermoDox
Dendreon Analysts Getting Very Skeptical
Seeking Alpha
Wednesday, May 22, 2013 - 11:52am
tags:
Dendreon
The 5 Highest-Paying Dividend Stocks in Big Pharma
Motley Fool
Wednesday, May 22, 2013 - 11:51am
tags:
dividends, AbbVie, Eli Lilly, Merck, GSK, AstraZeneca
U.S. government taps GlaxoSmithKline for new antibiotics
Reuters
Wednesday, May 22, 2013 - 10:20am
tags:
government contracts, GSK, antibiotics
A Boehringer Shake Up And An FDA Warning Letter Over Production Gaffes
Pharmalot
Wednesday, May 22, 2013 - 10:19am
tags:
FDA, warnings, Boehringer Ingelheim, drug manufacturing
Gilead's sofosbuvir gets EMA validation, now under assessment
The Fly on the Wall
Wednesday, May 22, 2013 - 10:16am
tags:
Gilead, Europe, sofosbuvir, hepatitis C
Biogen Idec submits Plegridy to FDA for multiple sclerosis patients with relapsed disease
Yahoo/AP
Wednesday, May 22, 2013 - 9:43am
tags:
Biogen Idec, MS, multiple sclerosis, FDA, Plegridy
Positive Data on Novo Nordisk's N9-GP
Yahoo/Zacks
Wednesday, May 22, 2013 - 9:41am
tags:
Novo Nordisk, N9-GP, hemophilia B

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.